Cerná M, Rössner P, Angelis K, Nováková J, Srám R J
Mutat Res. 1980 Jan;77(1):13-20.
Human blood and urine mutagenicity of 3-(5-nitro-2-furyl)acrylic acid (5-NFA) was analysed by using Salmonella typhimurium indicator strains TA100 AND TA98 and the cytogenetic analysis of human peripheral lymphocytes. 8 human volunteers were given doses of 1 g 5-NFA per os. The mutagenic effect in blood was analysed after 0, 0.5, 1, 2 and 4 h, in urine after 0, 2 and 4 h. Cytogenetic analysis was done 0, 24 and 72 h after administration of 5-NFA. The experiment was repeated with 3 volunteers in the course of 96 h. When each of 8 volunteers consumed 1 g of 5-NFA, the mutagenicity was observed in 6 blood samples 1 h after exposure for strain TA98 (doubled number or revertants) and in all urine samples taken between the 2nd and 6th hours for both strains used. 7 volunteers given 10 mg 5-NFA in wine (2 sets) showed no mutagenicity of blood or urine for TA100 or TA98 indicator strains. These results are believed to indicate an enhanced elimination of 5-NFA from the human body.
采用鼠伤寒沙门氏菌指示菌株TA100和TA98以及人外周血淋巴细胞的细胞遗传学分析方法,对3-(5-硝基-2-呋喃基)丙烯酸(5-NFA)的人体血液和尿液致突变性进行了分析。8名人类志愿者口服1 g 5-NFA。分别于0、0.5、1、2和4小时后分析血液中的诱变效应,于0、2和4小时后分析尿液中的诱变效应。在给予5-NFA后的0、24和72小时进行细胞遗传学分析。3名志愿者在96小时内重复进行了该实验。当8名志愿者每人摄入1 g 5-NFA时,暴露1小时后,在6份血液样本中观察到TA98菌株的致突变性(回复突变体数量翻倍),并且在使用的两种菌株的第2至6小时采集的所有尿液样本中也观察到致突变性。7名志愿者在葡萄酒中服用10 mg 5-NFA(2组),对于TA100或TA98指示菌株,血液或尿液均未显示致突变性。这些结果被认为表明人体对5-NFA的清除增强。